Xin Lang Cai Jing·2025-11-10 06:05Core Viewpoint - Spring Medical experienced a decline of 2.38% in stock price on November 7, with a trading volume of 83.6 million yuan, indicating potential market volatility and investor sentiment concerns [1] Financing Summary - On November 7, Spring Medical had a financing buy-in amount of 7.79 million yuan and a financing repayment of 8.40 million yuan, resulting in a net financing outflow of 0.62 million yuan [1] - The total financing and securities balance as of November 7 was 47.58 million yuan, which represents 0.62% of the circulating market value and is above the 90th percentile level over the past year, indicating a high financing balance [1] - No shares were sold or repaid in the securities lending market on November 7, with a total securities lending balance of 0, which is also above the 80th percentile level over the past year, suggesting a lack of short-selling activity [1] Company Overview - Beijing Spring Medical Equipment Co., Ltd. specializes in the research, production, and sales of implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants [2] - The company was established on February 12, 1998, and went public on December 30, 2021, with a revenue composition of 99.89% from medical device products [2] - As of September 30, 2025, Spring Medical reported a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, reflecting a significant increase of 213.21% year-on-year [2] Dividend and Shareholder Information - Since its A-share listing, Spring Medical has distributed a total of 359 million yuan in dividends, with 309 million yuan distributed over the past three years [3] - As of September 30, 2025, the company had 6,164 shareholders, an increase of 4.12% from the previous period, with an average of 46,906 circulating shares per shareholder, a decrease of 3.95% [2][3] - Notable institutional shareholders include Hong Kong Central Clearing Limited and China Europe Economic Growth Mixed Fund, both of which are new entrants among the top ten circulating shareholders [3]